Abstract
The use of stem cells in the treatment of primary immunodeficiencies has been studied for the past twenty years and shows a rising potential in the ability to decrease associated symptoms.
Recommended Citation
Storozynsky, Danielle
(2016)
"Use of Stem Cells in the Treatment of Type 1 Diabetes Mellitus and Multiple Sclerosis,"
Osmosis Magazine: Vol. 2016:
Iss.
1, Article 13.
Available at:
https://scholarship.richmond.edu/osmosis/vol2016/iss1/13
COinS
